China’s NMPA announced the issuance of a Special Drug Approval Certificate on 17-Nov-2025, marking a key step in enhancing digital Regulatory processes. The update confirms that administrative counterparts can now access, view, and print electronic drug approval licenses through the NMPA Government Service Portal, available since 26-Mar-2024.

Key Highlights:

  • Special Drug Approval Certificate issued on 17-Nov-2025
  • Authorized users can access electronic approval licenses via the NMPA service portal
  • Electronic access supports faster verification and document retrieval
  • Update includes serial and reception numbers for approvals issued on 14-Nov-2025

This update improves efficiency in China’s drug approval and license management system.

Consult Now

Source
https://www.nmpa.gov.cn/zwfw/sdxx/tsyp/tsyppjfb/20251117135350157.html
Select Mandate HA
NMPA
Select Mandate Function
Regulatory Affairs